ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
123.906,55
-0,32%
S&P 500
5.460,48
-0,41%
US Dollar vs BRL
5,59338
0,00%
Bitcoin
61.627,89
1,21%
Brent Oil
84,85
0,00%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Vascular Biogenics Ltd (VBLT)

  7. Vascular Biogenics Ltd (VBLT) Notícias

VBLT

Vascular Biogenics (VBLT)

Vascular Biogenics Ltd
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:VBLT
DataHoraFonteTítuloCódigoCompanhia
20/06/202418:01Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:VBLTVascular Biogenics Ltd
10/05/202418:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VBLTVascular Biogenics Ltd
06/05/202417:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBLTVascular Biogenics Ltd
19/04/202417:56Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:VBLTVascular Biogenics Ltd
11/04/202418:00Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:VBLTVascular Biogenics Ltd
01/04/202417:30Edgar (US Regulatory)Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405NASDAQ:VBLTVascular Biogenics Ltd
16/02/202411:00Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:VBLTVascular Biogenics Ltd
05/02/202419:00Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:VBLTVascular Biogenics Ltd
11/01/202419:22Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:VBLTVascular Biogenics Ltd
08/01/202418:21Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:VBLTVascular Biogenics Ltd
29/11/202319:15Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:VBLTVascular Biogenics Ltd
26/10/202318:15Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:VBLTVascular Biogenics Ltd
26/10/202318:15Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:VBLTVascular Biogenics Ltd
19/10/202314:34Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:VBLTVascular Biogenics Ltd
17/10/202318:01Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:VBLTVascular Biogenics Ltd
10/10/202309:01Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:VBLTVascular Biogenics Ltd
02/10/202318:29Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:VBLTVascular Biogenics Ltd
06/09/202301:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:VBLTVascular Biogenics Ltd
05/09/202316:52Edgar (US Regulatory)Form S-4/A - Registration of securities, business combinations: [Amend]NASDAQ:VBLTVascular Biogenics Ltd
14/08/202309:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VBLTVascular Biogenics Ltd
09/06/202317:32Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:VBLTVascular Biogenics Ltd
15/05/202317:46Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:VBLTVascular Biogenics Ltd
15/05/202317:11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VBLTVascular Biogenics Ltd
18/04/202317:37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VBLTVascular Biogenics Ltd
14/03/202309:02Edgar (US Regulatory)Annual Report (10-k)NASDAQ:VBLTVascular Biogenics Ltd
09/12/202219:15Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:VBLTVascular Biogenics Ltd
18/11/202208:15TipRanksH.C. Wainwright Reaffirms Their Hold Rating on Vascular Biogenics (VBLT)NASDAQ:VBLTVascular Biogenics Ltd
20/07/202209:55TipRanksVascular Biogenics (VBLT) Receives a Hold from JonesTradingNASDAQ:VBLTVascular Biogenics Ltd
20/07/202207:15TipRanksAnalysts Offer Insights on Healthcare Companies: Celsion (CLSN), Vascular Biogenics (VBLT) and Portage Biotech Inc (PRTG)NASDAQ:VBLTVascular Biogenics Ltd
20/05/202214:25TipRanksJonesTrading Remains a Buy on Vascular Biogenics (VBLT)NASDAQ:VBLTVascular Biogenics Ltd
 Apresentando as notícias mais relevantes sobre:NASDAQ:VBLT

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
PRIO3
PETRORIO ON
BOV
GOLL4
GOL PN
BOV
PETR4
PETROBRAS PN
BOV
IDIV
Dividend
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados